Works matching DE "GLUCAGON-like peptide-1 receptor"
Results: 1943
Obesity A therapeutic target in people with cardiovascular disease.
- Published in:
- Medicine Today, 2024, v. 25, n. 12, p. 23
- By:
- Publication type:
- Article
Effects of Anti-Diabetic Drugs on Erectile Dysfunction: A Systematic Review and Meta-Analysis.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2025, v. 18, p. 467, doi. 10.2147/DMSO.S503216
- By:
- Publication type:
- Article
Efficacy and Safety of Glucagon Like Peptide-1 Receptor Agonism Based Therapies in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis.
- Published in:
- Indian Journal of Endocrinology & Metabolism, 2025, v. 29, n. 1, p. 4, doi. 10.4103/ijem.ijem_365_24
- By:
- Publication type:
- Article
GLP-1 receptor agonists—another promising therapy for Alport syndrome?
- Published in:
- Journal of Rare Diseases, 2025, v. 4, n. 1, p. 1, doi. 10.1007/s44162-024-00065-8
- By:
- Publication type:
- Article
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 238, doi. 10.3390/pharmaceutics17020238
- By:
- Publication type:
- Article
Exploring the Putative Involvement of MALAT1 in Mediating the Beneficial Effect of Exendin-4 on Oleic Acid-Induced Lipid Accumulation in HepG2 Cells.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 370, doi. 10.3390/biomedicines13020370
- By:
- Publication type:
- Article
Diabetes Mellitus in Kidney Transplant Recipients: New Horizons in Treatment.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1048, doi. 10.3390/jcm14041048
- By:
- Publication type:
- Article
A Hypothesis That Glucagon-like Peptide-1 Receptor Agonists Exert Immediate and Multifaceted Effects by Activating Adenosine Monophosphate-Activate Protein Kinase (AMPK).
- Published in:
- Life (2075-1729), 2025, v. 15, n. 2, p. 253, doi. 10.3390/life15020253
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 (SGLT2) inhibitors and risk of chronic kidney disease–mineral and bone disorders in patients with type 2 diabetes mellitus and stage 1–3 chronic kidney disease.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2025, v. 197, n. 7, p. E178, doi. 10.1503/cmaj.240922
- By:
- Publication type:
- Article
Myocardial Protection Against Ischemia-Reperfusion Injury by GLP-1: Molecular Mechanisms.
- Published in:
- Metabolic Syndrome & Related Disorders, 2012, v. 10, n. 6, p. 387, doi. 10.1089/met.2012.0095
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonists for Abdominal Aortic Aneurysm?
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 13, doi. 10.1007/s10557-024-07647-0
- By:
- Publication type:
- Article
Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 4, p. 739, doi. 10.1007/s10557-023-07432-5
- By:
- Publication type:
- Article
Inadequate Use of Newer Treatments and Glycemic Control by Cardiovascular Risk and Sociodemographic Groups in US Adults with Diabetes in the NIH Precision Medicine Initiative All of Us Research Program.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 2, p. 347, doi. 10.1007/s10557-022-07403-2
- By:
- Publication type:
- Article
Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 2, p. 371, doi. 10.1007/s10557-022-07360-w
- By:
- Publication type:
- Article
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery Disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1161, doi. 10.1007/s10557-021-07160-8
- By:
- Publication type:
- Article
New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 1, p. 10, doi. 10.1007/s10157-012-0709-0
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors and the risk of venous thromboembolism: A nationwide population‐based study and meta‐analysis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 2, p. 1, doi. 10.1002/dmrr.3739
- By:
- Publication type:
- Article
Effects of treatment with Glucagon‐like peptide‐1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta‐analysis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 7, p. 1, doi. 10.1002/dmrr.3680
- By:
- Publication type:
- Article
Pleiotropic effects of GLP‐1 receptor agonists on peripheral artery disease: Is there any hope?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 7, p. 1, doi. 10.1002/dmrr.3627
- By:
- Publication type:
- Article
Changing the approach to type 2 diabetes treatment: A comparison of glucagon‐like peptide‐1 receptor agonists and sulphonylureas across the continuum of care.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 7, p. 1, doi. 10.1002/dmrr.3434
- By:
- Publication type:
- Article
GLP‐1 RA and atrial fibrillation in the cardiovascular outcome trials.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 5, p. 1, doi. 10.1002/dmrr.3436
- By:
- Publication type:
- Article
A multifaceted approach for management of prediabetes and its associated cardiovascular risk.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Liraglutide on Osteoporosis in a Rat Model of Type 2 Diabetes Mellitus: A Histological, Immunohistochemical, and Biochemical Study.
- Published in:
- Microscopy & Microanalysis, 2023, v. 29, n. 6, p. 2053, doi. 10.1093/micmic/ozad102
- By:
- Publication type:
- Article
Sodium glucose cotransporter 2 inhibitors and gout risk: a sequence symmetry analysis.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 9, p. 2469, doi. 10.1007/s10067-023-06647-z
- By:
- Publication type:
- Article
Duodenal-jejunal bypass changes the composition of the gut microbiota.
- Published in:
- Surgery Today, 2017, v. 47, n. 1, p. 137, doi. 10.1007/s00595-016-1373-x
- By:
- Publication type:
- Article
Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats.
- Published in:
- Surgery Today, 2016, v. 46, n. 9, p. 1099, doi. 10.1007/s00595-015-1287-z
- By:
- Publication type:
- Article
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).
- Published in:
- JMIR Research Protocols, 2022, v. 11, n. 7, p. 1, doi. 10.2196/34206
- By:
- Publication type:
- Article
The Ups and Downs of Non-Insulin Therapies: The Agony of Choice.
- Published in:
- Clinical Management Issues, 2019, v. 13, n. 1, p. 19, doi. 10.7175/cmi.v13i1.1426
- By:
- Publication type:
- Article
'No Observed Increase' in Pancreatic Cancer Among Patients with Type 2 Diabetes on GLP-1RAs.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 37
- By:
- Publication type:
- Article
GLP-1RAs May Offer 'Hepatoprotective' Benefit for Diabetes, Alcohol-Related Liver Disease.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 32
- By:
- Publication type:
- Article
'No Observed Increase' in Pancreatic Cancer Among Patients With Type 2 Diabetes on GLP-1RAs.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 11, p. 32
- By:
- Publication type:
- Article
GLP-1RA Use Linked With Risk for Food Retention in Single Endoscopic Procedures.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 11, p. 14
- By:
- Publication type:
- Article
'Encouraging' Data: GLP-1RAs Linked to Lower Risk for Cirrhosis in MASLD, Type 2 Diabetes.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 6, p. 36
- By:
- Publication type:
- Article
GLP-1RA Use in MAFLD, Obesity Lowers Mortality, 'Provides Cardiovascular Benefits'.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 6, p. 33
- By:
- Publication type:
- Article
GLP-1RAs Associated With Increased Residual Gastric Content, Despite Preprocedural Fasting.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 5, p. 36
- By:
- Publication type:
- Article
Holding GLP-1RAs Before Endoscopy 'Is Justified' to Reduce Risk for Aspiration Pneumonia.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 5, p. 32
- By:
- Publication type:
- Article
Effects of semaglutide on gut microbiota, cognitive function and inflammation in obese mice.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17891
- By:
- Publication type:
- Article
Oleanolic acid and moderate drinking increase the pancreatic GLP-1R expression of the β-cell mass deficiency induced hyperglycemia.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.15705
- By:
- Publication type:
- Article
Quality of care and prescription patterns among patients with diabetic kidney disease-a large-scale cohort study from Taiwanese clinics.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.13636
- By:
- Publication type:
- Article
Dietary squid paste supplementation promotes feed intake via brain-gut dynamic response in Chinese soft-shelled turtle Pelodiscus sinensis.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.9031
- By:
- Publication type:
- Article
A glucagon-like peptide-1 analog, liraglutide, ameliorates endothelial dysfunction through miRNAs to inhibit apoptosis in rats.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.6567
- By:
- Publication type:
- Article
Equine glucagon-like peptide-1 receptor physiology.
- Published in:
- PeerJ, 2018, p. 1, doi. 10.7717/peerj.4316
- By:
- Publication type:
- Article
Gut AstA mediates sleep deprivation-induced energy wasting in Drosophila.
- Published in:
- Cell Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41421-023-00541-3
- By:
- Publication type:
- Article
Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a single-institution retrospective cohort study of tolerability and weight loss.
- Published in:
- Neurological Sciences, 2025, v. 46, n. 1, p. 343, doi. 10.1007/s10072-024-07701-7
- By:
- Publication type:
- Article
GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 7, p. 2911, doi. 10.1007/s10072-020-04910-8
- By:
- Publication type:
- Article
Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 7, p. 2033, doi. 10.1007/s11136-021-02808-2
- By:
- Publication type:
- Article
Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes.
- Published in:
- Journal of Diabetes Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/176949
- By:
- Publication type:
- Article
Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor.
- Published in:
- Journal of Physiology, 2012, v. 590, n. 20, p. 5245, doi. 10.1113/jphysiol.2012.234914
- By:
- Publication type:
- Article
SELECT: Glucagon-like peptide-1 receptor agonist in obese patients with cardiovascular disease in the absence of diabetes.
- Published in:
- Global Cardiology Science & Practice, 2024, v. 2024, n. 4, p. 1, doi. 10.21542/gcsp.2024.26
- By:
- Publication type:
- Article